Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gianni Bisogno

Showing results (1-10 of 325) with videos related to

Pageof 33
Sort By:
European Journal of Pediatrics|August 10, 2006
Persistent B-cell depletion after rituximab for thrombocytopenic purpuraGianni Bisogno
Pediatric Blood & Cancer|November 23, 2013
Can high dose methotrexate be continued after severe hypersensitivity reaction?Antonio Marzollo, Gianni Bisogno
Pediatric Blood & Cancer|January 30, 2020
An unresolved issue in rhabdomyosarcoma treatment: The duration of chemotherapyGianni Bisogno, Douglas S Hawkins
Methods in Molecular Biology (Clifton, N.J.)|December 24, 2018
Cell-Free DNA in Pediatric Rhabdomyosarcoma: Potential and ChallengesLucia Tombolan, Angelica Zin, Gianni Bisogno
Pediatric Blood & Cancer|December 17, 2004
Interferon alpha for alveolar soft part sarcomaGianni Bisogno, Angelo Rosolen, Modesto Carli
Paediatric Drugs|August 21, 2007
Management of childhood malignant peripheral nerve sheath tumorAndrea Ferrari, Gianni Bisogno, Modesto Carli
The Journal of Pediatrics|November 18, 2005
Rituximab and factors predictive of response in chronic immune thrombocytopenic purpura of childrenSimone Cesaro, Gianni Bisogno, Anna Pusiol
Orphanet Journal of Rare Diseases|April 14, 2010
Thrombocytopenia and splenomegaly: an unusual presentation of congenital hepatic fibrosisSerena Botto Poala, Gianni Bisogno, Raffaella Colombatti
Pediatric Blood & Cancer|September 12, 2020
Introducing INSTRuCT: An international effort to promote cooperation and data sharingDouglas S Hawkins, Gianni Bisogno, Ewa Koscielniak
Expert Review of Anticancer Therapy|December 25, 2012
The founding of the European Cooperative Study Group on Pediatric Rare Tumors--EXPeRTAndrea Ferrari, Dominik T Schneider, Gianni Bisogno, et al.
Pageof 33

Showing results (1-10 of 325) with videos related to

Sort By:
Pageof 33
European Journal of Pediatrics|August 10, 2006
Persistent B-cell depletion after rituximab for thrombocytopenic purpuraGianni Bisogno
Pediatric Blood & Cancer|November 23, 2013
Can high dose methotrexate be continued after severe hypersensitivity reaction?Antonio Marzollo, Gianni Bisogno
Pediatric Blood & Cancer|January 30, 2020
An unresolved issue in rhabdomyosarcoma treatment: The duration of chemotherapyGianni Bisogno, Douglas S Hawkins
Methods in Molecular Biology (Clifton, N.J.)|December 24, 2018
Cell-Free DNA in Pediatric Rhabdomyosarcoma: Potential and ChallengesLucia Tombolan, Angelica Zin, Gianni Bisogno
Pediatric Blood & Cancer|December 17, 2004
Interferon alpha for alveolar soft part sarcomaGianni Bisogno, Angelo Rosolen, Modesto Carli
Paediatric Drugs|August 21, 2007
Management of childhood malignant peripheral nerve sheath tumorAndrea Ferrari, Gianni Bisogno, Modesto Carli
The Journal of Pediatrics|November 18, 2005
Rituximab and factors predictive of response in chronic immune thrombocytopenic purpura of childrenSimone Cesaro, Gianni Bisogno, Anna Pusiol
Orphanet Journal of Rare Diseases|April 14, 2010
Thrombocytopenia and splenomegaly: an unusual presentation of congenital hepatic fibrosisSerena Botto Poala, Gianni Bisogno, Raffaella Colombatti
Pediatric Blood & Cancer|September 12, 2020
Introducing INSTRuCT: An international effort to promote cooperation and data sharingDouglas S Hawkins, Gianni Bisogno, Ewa Koscielniak
Expert Review of Anticancer Therapy|December 25, 2012
The founding of the European Cooperative Study Group on Pediatric Rare Tumors--EXPeRTAndrea Ferrari, Dominik T Schneider, Gianni Bisogno, et al.
Pageof 33